无药体外激活卵泡用于卵巢储备下降的卵巢低反应患者不孕治疗
本研究为病例系列研究,纳入11例卵巢储备下降的卵巢低反应患者,采用简化无药体外激活(仅卵巢皮质碎片化)联合自体移植。9例患者经FSH刺激后出现多波窦卵泡数增加,获更多成熟卵用于IVF,中位窦卵泡数由1.0增至2.6,受精率68.7%,56.9%显示高质量胚胎发育。5例患者中1例自然妊娠、16次胚胎移植后获1例活产、2例持续妊娠和1例流产。
要点
- 无药IVA(仅皮质碎片化)可使9/11例POR伴DOR患者窦卵泡数增加。
- 中位窦卵泡数由1.0增至2.6,受精率68.7%,56.9%高质量胚胎发育。
- 5例患者16次胚胎移植后获1例活产、2例持续妊娠、1例流产。
核心结论
- 无药IVA可能适用于卵巢储备下降的卵巢低反应患者,因其增加了窦卵泡数。
- 该操作无需2天药物孵育且仅需一次手术。
- 该方法可能使中年女性获取更多卵母细胞以获得更高妊娠率,值得未来随机对照试验评估。
研究设计与样本
- 病例系列研究,纳入11例卵巢储备下降的卵巢低反应患者。
主要发现
- 9/11例POR伴DOR患者经简化IVA后FSH治疗出现多波窦卵泡数增加。
- 中位窦卵泡数(每次卵巢刺激前 vs 后)为1.0 vs 2.6。
- 受精率68.7%,56.9%显示高质量胚胎发育。
- 5例患者中1例自然妊娠、16次胚胎移植后获1例活产、2例持续妊娠和1例流产。
- 另有3例患者及流产患者已冻存胚胎供未来移植。
临床怎么用
- 无药IVA通过卵巢皮质碎片化联合自体移植,可能为POR伴DOR患者增加窦卵泡数并获取更多成熟卵。
- 该操作无需2天药物孵育且仅需一次手术。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: The recently developed in-vitro activation (IVA) approach provides a promising infertility treatment for patients with premature ovarian insufficiency. The IVA method promotes growth of residual ovarian follicles following ovarian tissue fragmentation leading to Hippo signalling disruption, together with in-vitro incubation with Akt stimulators. As poor ovarian response (POR) patients with decreased ovarian reserve (DOR) have multiple secondary follicles, this study tested whether Hippo signalling disruption alone using in-vitro ovarian cortical fragmentation, followed by autologous grafting, was sufficient to promote follicle growth. DESIGN: A case series study. RESULTS: In 9 out of 11 POR patients with DOR treated with a simplified IVA procedure, increases in antral follicle numbers in multiple growth waves were detected following FSH treatment. Subsequent injection with human chorionic gonadotrophin allowed retrieval of more mature oocytes for IVF (median antral follicle counts before and after IVA per ovarian stimulation: 1.0 versus 2.6) with 68.7% fertilization rates and 56.9% showing high-quality embryonic development. One natural conception and 16 embryo transfers in five patients resulted in one live birth, two ongoing pregnancies and one miscarriage. Three additional patients and the miscarriage patient have cryopreserved embryos for future transfer. CONCLUSIONS: The present drug-free IVA approach may be suitable for POR patients with DOR, as it increased the number of antral follicles. The procedure also eliminated the need for 2-day incubation with drugs and required only one surgery. This approach could allow the retrieval of more oocytes in middle-aged women to achieve higher pregnancy rates and deserves proper evaluation in future randomized controlled trials.
引用
- Kawamura K, Ishizuka B, Hsueh AJW, et al. Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve. Reprod Biomed Online. 2019. PMID: 31753712. doi:10.1016/j.rbmo.2019.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。